Definitions and criteria for diabetic foot disease.


Journal

Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450

Informations de publication

Date de publication:
03 2020
Historique:
received: 01 05 2019
accepted: 01 08 2019
pubmed: 17 1 2020
medline: 23 1 2021
entrez: 17 1 2020
Statut: ppublish

Résumé

Multiple disciplines are involved in the management of diabetic foot disease, and a common vocabulary is essential for clear communication. Based on the systematic reviews of the literature that form the basis of the International Working Group on the Diabetic Foot (IWGDF) Guidelines, the IWGDF has developed a set of definitions and criteria for diabetic foot disease. This document describes these definitions and criteria. We suggest these definitions be used consistently in both clinical practice and research to facilitate clear communication between professionals.

Identifiants

pubmed: 31943705
doi: 10.1002/dmrr.3268
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3268

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

IWGDF Editorial Board. IWGDF Definitions and Criteria. 2019; Available at: https://iwgdfguidelines.org/definitions-criteria/. Accessed April 23, 2019.
Jeffcoate WJ, Bus SA, Game FL, et al. Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality. Lancet Diabetes Endocrinol. 2016 Sep;4(9):781-788.
Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, IWGDF Editorial Board. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev; 2020;36(S1):e3266.
Bus SA, Lavery LA, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev; 2020;36(S1):e3269.
Bus SA, Armstrong DG, Gooday C, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev; 2020;36(S1):e3274.
Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev; 2020;36(S1):e3276.
Lipsky BA, Senneville É, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev; 2020;36(S1):e3280.
Rayman G, Vas P, Dhatariya K, et al. Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update). Diabetes Metab Res Rev; 2020;36(S1):e3283.
Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev; 2020;36(S1):e3273.
Moore Z, Butcher G, Corbett LQ, McGuiness W, Snyder RJ, van Acker K. Exploring the concept of a team approach to wound care: managing wounds as a team. J Wound Care 2014 May;23 Suppl 5b:S1-S38.

Auteurs

Jaap J van Netten (JJ)

Amsterdam UMC, Department of Rehabilitation Medicine, Amsterdam Movement Sciences, Meibergdreef 9, Amsterdam, The Netherlands.
School of Clinical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Diabetic foot Clinic, Department of Surgery, Ziekenhuisgroep Twente, Almelo, The Netherlands.

Sicco A Bus (SA)

Amsterdam UMC, Department of Rehabilitation Medicine, Amsterdam Movement Sciences, Meibergdreef 9, Amsterdam, The Netherlands.

Jan Apelqvist (J)

Department of Endocrinology, University Hospital of Malmö, Sweden.

Benjamin A Lipsky (BA)

Department of Medicine, University of Washington, Seattle, WA.
Green Templeton College, University of Oxford, Oxford, UK.

Robert J Hinchliffe (RJ)

Bristol Centre for Surgical Research, University of Bristol, Bristol, UK.

Frances Game (F)

Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.

Gerry Rayman (G)

Diabetes Centre and Research Unit, East Suffolk and North East Essex Foundation Trust, Colchester, UK.

Peter A Lazzarini (PA)

School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
Allied Health Research Collaborative, The Prince Charles Hospital, Brisbane, Australia.

Rachael O Forsythe (RO)

British Heart Foundation, University of Edinburgh, Edinburgh, UK.
Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.

Edgar J G Peters (EJG)

Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Internal Medicine, Section of Infectious Diseases, Amsterdam Movement Sciences, Amsterdam, The Netherlands.

Éric Senneville (É)

Gustave Dron Hospital, Tourcoing, France.

Prashanth Vas (P)

Diabetes Foot Clinic, King's College Hospital, London, UK.

Matilde Monteiro-Soares (M)

MEDCIDES: Departamento de Medicina da Comunidade Informação e Decisão em Saúde & CINTESIS-Center for Health Technology and Services Research, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Nicolaas C Schaper (NC)

Division of Endocrinology, MUMC+, CARIM and CAPHRI Institute, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH